Matches in Wikidata for { <http://www.wikidata.org/entity/Q90088298> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90088298 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90088298 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90088298 description "scientific article published on 06 September 2019" @default.
- Q90088298 description "wetenschappelijk artikel" @default.
- Q90088298 description "наукова стаття, опублікована 6 вересня 2019" @default.
- Q90088298 name "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 name "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 type Item @default.
- Q90088298 label "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 label "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 prefLabel "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 prefLabel "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 P1433 Q90088298-0748BF0D-BBED-4EA2-B3D4-67363B179A9F @default.
- Q90088298 P1476 Q90088298-D22702C6-967D-442D-B3EA-97EA8B4D1105 @default.
- Q90088298 P2093 Q90088298-33D14BF4-A58C-4B06-9903-5D492D444294 @default.
- Q90088298 P2860 Q90088298-832CD91E-5D5E-4527-BCC8-3C7109F741F7 @default.
- Q90088298 P2860 Q90088298-9C010043-41A4-412D-BED5-AF47C18EEB83 @default.
- Q90088298 P304 Q90088298-8379C29A-6DA2-4992-AA0E-A13626F314D6 @default.
- Q90088298 P31 Q90088298-F5892001-A89B-453C-96DC-5E25BCB78EDE @default.
- Q90088298 P356 Q90088298-57BD47A5-BE68-4112-9DB3-37BEC9623469 @default.
- Q90088298 P478 Q90088298-874B90F2-D7F6-4537-A80E-FF08F6683D2B @default.
- Q90088298 P577 Q90088298-7448EE5B-E027-436E-8C9D-913240599886 @default.
- Q90088298 P698 Q90088298-3FC9BAE9-164D-43D2-B6DE-10FC0D742FF4 @default.
- Q90088298 P932 Q90088298-BE3D9172-04AE-4E83-95A7-F9276C6F6BA4 @default.
- Q90088298 P356 J.YMGMR.2019.100511 @default.
- Q90088298 P698 31516832 @default.
- Q90088298 P1433 Q27725363 @default.
- Q90088298 P1476 "Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders"" @default.
- Q90088298 P2093 "Barry Wolf" @default.
- Q90088298 P2860 Q91999093 @default.
- Q90088298 P2860 Q92999411 @default.
- Q90088298 P304 "100511" @default.
- Q90088298 P31 Q13442814 @default.
- Q90088298 P356 "10.1016/J.YMGMR.2019.100511" @default.
- Q90088298 P478 "21" @default.
- Q90088298 P577 "2019-09-06T00:00:00Z" @default.
- Q90088298 P698 "31516832" @default.
- Q90088298 P932 "6734048" @default.